home / stock / rdgl / rdgl news


RDGL News and Press, Vivos From 08/16/22

Stock Information

Company Name: Vivos
Stock Symbol: RDGL
Market: OTC
Website: radiogel.com

Menu

RDGL RDGL Quote RDGL Short RDGL News RDGL Articles RDGL Message Board
Get RDGL Alerts

News, Short Squeeze, Breakout and More Instantly...

RDGL - Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy

Richland WA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it just certified the New England Equine Practice in Patterson, NY to administer Precision Radionuclide IsoPet ® therapy for treating solid tumors in horses. ...

RDGL - Vivos Inc. Provides Intellectual Property Protection Update

Richland WA, May 12, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it expanded its intellectual property protection on several fronts. Our patent team filed our particle patent in more than ten patent offices that collectively cover 63 coun...

RDGL - Vivos Inc Implements Multiple Patient IsoPet® Therapy Day

Richland WA, April 21, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce a combined IsoPet ® therapy schedule into one treatment day, allowing for one production run to provide multiple Isopet ® therapies that are done in any one o...

RDGL - Vivos Inc. Enhances its Intellectual Property Protection

Richland WA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it filed its particle patent in several countries. Our new patent team filed the particle patent in the USA, Canada, the European Union, Japan, Australia, Brazil, China...

RDGL - Vivos Inc. Provides 2021 Recap and Outlines 2022 Objectives

Richland WA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2021 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2022, we wanted to review our progress during the past year and provide insights on our thinki...

RDGL - Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel(TM)

Richland WA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), on November 30 Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of the Investigational Device Exemption, which is necessary to initiate clinical testing in hu...

RDGL - Vivos Inc Announces Johns Hopkins University (Veterinary Clinical Trials Network) is a New Regional Clinic for Isopet®

This replaces and corrects the press release from November 22. Johns Hopkins (VCTN) Veterinary Clinical Trials Network is our teaming partner not the Center for Image Guided Animal Therapy (CIGAT). Richland WA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos ...

RDGL - Vivos Inc Announces John Hopkins University as a New Regional Clinic for Isopet®

Richland WA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that John Hopkins University Center for Image Guided Animal Therapy (CIGAT) is now an Isopet ® regional clinic. Additionally, Johns Hopkins will also perform new Isopet ...

RDGL - Vivos Inc Signs a MOU for a New Regional Clinic in NY for IsoPet Therapy

Richland WA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it signed a Memorandum of Understanding with the Animal Hospital Surgical Center in East Meadow New York on Long Island to become an IsoPet regional therapy center. Vivos Inc is curre...

RDGL - Vivos Inc Completes Certification Training Modules for Future IsoPet® Therapy Regional Clinics

Richland WA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc working with FX Masse completed nine certification training modules that are part of the certification training for new regional clinics. The modules are now on the FX Masse website with a sepa...

Previous 10 Next 10